首页 > 最新文献

Middle East African Journal of Ophthalmology最新文献

英文 中文
A Novel Snake-chain Metal Probed Silicon Intubation Set for Nasolacrimal Duct Intubation: A Cadaveric Feasibility Study. 用于鼻泪管插管的新型蛇链金属探针硅插管装置:尸体可行性研究。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_32_24
Omar M Solyman, Saul N Rajak

Purpose: A fresh-frozen human cadaveric feasibility study to investigate the feasibility of probing and stenting the nasolacrimal ducts (NLDs) of human cadavers with a novel flexible bicanalicular nasolacrimal stent.

Methods: A custom-designed bicanalicular nasolacrimal stent was made by connecting a 250 mm long, 0.9 mm diameter silicone tube to a 200 mm long stainless-steel, snake-chain probe at each end. The punctum was dilated, and the snake-chain stent fed into the nasolacrimal drainage system. The emergence of the stents from the terminal end of the NLD and retrieval with a ball probe was conducted under endoscopic guidance.

Results: Bicanalicular nasolacrimal stenting with intranasal retrieval under endoscopic guidance was successfully achieved in six NLDs of three adult cadaveric nasolacrimal drainage systems.

Conclusion: Despite being soft and flexible, the snake-chain silicon stent passes smoothly and freely through cadaveric human NLD and is easily retrieved from the nasal cavity. This novel NLD stent design may make stenting of the NLD easier and less traumatic.

目的:一项新鲜冷冻人体尸体可行性研究,旨在探讨使用新型柔性双腔鼻泪管支架对人体尸体的鼻泪管(NLD)进行探查和支架植入的可行性:方法:通过将一根长 250 毫米、直径 0.9 毫米的硅胶管与一根长 200 毫米的不锈钢蛇链探针两端连接起来,制作了一个定制的双腔鼻泪管支架。扩张穿刺孔后,蛇链支架进入鼻泪管引流系统。在内窥镜引导下,支架从鼻泪管末端伸出,并用球形探针取出:结果:在内窥镜引导下,在三个成人尸体鼻泪管引流系统的六个鼻泪管中成功实现了双腔鼻泪管支架植入和鼻内取出:结论:尽管蛇链硅支架柔软而有弹性,但它能顺利而自由地通过人体尸体的 NLD,并很容易从鼻腔内取出。这种新颖的鼻泪管支架设计可使鼻泪管支架置入手术更容易,创伤更小。
{"title":"A Novel Snake-chain Metal Probed Silicon Intubation Set for Nasolacrimal Duct Intubation: A Cadaveric Feasibility Study.","authors":"Omar M Solyman, Saul N Rajak","doi":"10.4103/meajo.meajo_32_24","DOIUrl":"https://doi.org/10.4103/meajo.meajo_32_24","url":null,"abstract":"<p><strong>Purpose: </strong>A fresh-frozen human cadaveric feasibility study to investigate the feasibility of probing and stenting the nasolacrimal ducts (NLDs) of human cadavers with a novel flexible bicanalicular nasolacrimal stent.</p><p><strong>Methods: </strong>A custom-designed bicanalicular nasolacrimal stent was made by connecting a 250 mm long, 0.9 mm diameter silicone tube to a 200 mm long stainless-steel, snake-chain probe at each end. The punctum was dilated, and the snake-chain stent fed into the nasolacrimal drainage system. The emergence of the stents from the terminal end of the NLD and retrieval with a ball probe was conducted under endoscopic guidance.</p><p><strong>Results: </strong>Bicanalicular nasolacrimal stenting with intranasal retrieval under endoscopic guidance was successfully achieved in six NLDs of three adult cadaveric nasolacrimal drainage systems.</p><p><strong>Conclusion: </strong>Despite being soft and flexible, the snake-chain silicon stent passes smoothly and freely through cadaveric human NLD and is easily retrieved from the nasal cavity. This novel NLD stent design may make stenting of the NLD easier and less traumatic.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"164-167"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spondyloarthritis Associated with Uveitis: A Review. 与葡萄膜炎相关的脊柱关节炎:综述。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_132_21
Hamza Toufik, Mohammed A Ghassem, Abderrahim Majjad, Aziza Mounach, Ahmed Bezza

Spondyloarthritis (SpA) is a group of chronic inflammatory rheumatism characterized by common clinical, radiological, and biological manifestations occurring on a predisposing genetic background dominated by the HLA-B27 antigen. Acute anterior uveitis is the most common extra-articular feature of SpA. The objective of this review is to describe the prevalence, demographic characteristics, factors favoring the occurrence of uveitis in patients with SpA, clinical manifestations, and their therapeutic management.

脊柱关节炎(Spondyloarthritis,SPA)是一组慢性炎症性风湿病,其特点是在以 HLA-B27 抗原为主的易感遗传背景下出现常见的临床、放射学和生物学表现。急性前葡萄膜炎是 SpA 最常见的关节外特征。本综述旨在描述 SpA 患者葡萄膜炎的发病率、人口统计学特征、诱发因素、临床表现及其治疗方法。
{"title":"Spondyloarthritis Associated with Uveitis: A Review.","authors":"Hamza Toufik, Mohammed A Ghassem, Abderrahim Majjad, Aziza Mounach, Ahmed Bezza","doi":"10.4103/meajo.meajo_132_21","DOIUrl":"https://doi.org/10.4103/meajo.meajo_132_21","url":null,"abstract":"<p><p>Spondyloarthritis (SpA) is a group of chronic inflammatory rheumatism characterized by common clinical, radiological, and biological manifestations occurring on a predisposing genetic background dominated by the HLA-B27 antigen. Acute anterior uveitis is the most common extra-articular feature of SpA. The objective of this review is to describe the prevalence, demographic characteristics, factors favoring the occurrence of uveitis in patients with SpA, clinical manifestations, and their therapeutic management.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"177-181"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Clinical Study on Severity of Dry Eye in Individuals with Pterygium at a Tertiary Hospital in South Kerala. 关于南喀拉拉邦一家三甲医院翼状胬肉患者干眼症严重程度的临床研究。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_65_23
Hari Ramakrishnan, Jewel John

Purpose: To assess the severity of dry eye in individuals with pterygium in a tertiary care hospital.

Methods: This cross-sectional study was done on 70 individuals with pterygium who were attending the outpatient department of ophthalmology. Objective dry eye tests were done, including Schirmer's tests 1 and 2, tear film breakup time, and tear meniscus height (TMH). In this study, patients with one or more positive clinical tests were diagnosed to have dry eyes. Dry eye was graded as mild, moderate, severe, or severe disabling.

Results: Among 140 eyes, 79 eyes had pterygium. According to Schirmer's test 1 in eyes with pterygium, 29.1% of the eyes had mild dry eyes, and 26.6% had moderate dry eyes. According to Schirmer's test 2 in eyes with pterygium, 25.3% of the eyes had mild dry eyes, and 26.6% had moderate dry eyes. Tear film breakup time in eyes with pterygium showed a mild dry eye in 25.3% and moderate dry eye in 17.7%. TMH in eyes with pterygium was low at 7.6%.

Conclusion: The majority of eyes with pterygium have mild or moderate dry eye according to Schirmer's test 1, Schirmer's test 2, and tear film breakup time. No eyes with pterygium have severe dry eyes. TMH was also low in a small proportion of eyes with pterygium. Dry eye evaluation by Schirmer's test and tear breakup time is, therefore, a crucial clinical tool for early detection and prompt management of dry eye syndrome in pterygium patients.

目的:评估一家三级医院中翼状胬肉患者干眼症的严重程度:这项横断面研究的对象是在眼科门诊部就诊的 70 名翼状胬肉患者。进行了客观的干眼测试,包括施尔默试验 1 和 2、泪膜破裂时间和泪液半月板高度(TMH)。在这项研究中,有一项或多项临床测试呈阳性的患者被诊断为干眼症。干眼分为轻度、中度、重度或重度致残:在 140 只眼睛中,有 79 只眼睛患有翼状胬肉。根据翼状胬肉患者的 Schirmer's 测试 1,29.1% 的人患有轻度干眼症,26.6% 的人患有中度干眼症。根据施尔默试验 2,患有翼状胬肉的眼睛中有 25.3% 患有轻度干眼症,26.6% 患有中度干眼症。翼状胬肉患者的泪膜破裂时间显示,25.3% 的人患有轻度干眼症,17.7% 的人患有中度干眼症。翼状胬肉患者的泪膜破裂时间较低,仅为 7.6%:根据Schirmer测试1、Schirmer测试2和泪膜破裂时间,大多数患有翼状胬肉的眼睛都有轻度或中度干眼症。没有患有翼状胬肉的眼睛患有重度干眼症。在一小部分患有翼状胬肉的眼睛中,TMH 也很低。因此,通过施尔默试验和泪膜破裂时间评估干眼症是早期发现和及时处理翼状胬肉患者干眼症的重要临床工具。
{"title":"A Clinical Study on Severity of Dry Eye in Individuals with Pterygium at a Tertiary Hospital in South Kerala.","authors":"Hari Ramakrishnan, Jewel John","doi":"10.4103/meajo.meajo_65_23","DOIUrl":"https://doi.org/10.4103/meajo.meajo_65_23","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the severity of dry eye in individuals with pterygium in a tertiary care hospital.</p><p><strong>Methods: </strong>This cross-sectional study was done on 70 individuals with pterygium who were attending the outpatient department of ophthalmology. Objective dry eye tests were done, including Schirmer's tests 1 and 2, tear film breakup time, and tear meniscus height (TMH). In this study, patients with one or more positive clinical tests were diagnosed to have dry eyes. Dry eye was graded as mild, moderate, severe, or severe disabling.</p><p><strong>Results: </strong>Among 140 eyes, 79 eyes had pterygium. According to Schirmer's test 1 in eyes with pterygium, 29.1% of the eyes had mild dry eyes, and 26.6% had moderate dry eyes. According to Schirmer's test 2 in eyes with pterygium, 25.3% of the eyes had mild dry eyes, and 26.6% had moderate dry eyes. Tear film breakup time in eyes with pterygium showed a mild dry eye in 25.3% and moderate dry eye in 17.7%. TMH in eyes with pterygium was low at 7.6%.</p><p><strong>Conclusion: </strong>The majority of eyes with pterygium have mild or moderate dry eye according to Schirmer's test 1, Schirmer's test 2, and tear film breakup time. No eyes with pterygium have severe dry eyes. TMH was also low in a small proportion of eyes with pterygium. Dry eye evaluation by Schirmer's test and tear breakup time is, therefore, a crucial clinical tool for early detection and prompt management of dry eye syndrome in pterygium patients.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"149-155"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Artificial Intelligence Programs' Understanding of Lens, Cataract, and Refractive Surgery Information. 探索人工智能程序对透镜、白内障和屈光手术信息的理解。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_199_23
Eyupcan Sensoy, Mehmet Citirik

Purpose: We aimed to evaluate the success of Chat Generative Pre-trained Transformer (ChatGPT), Bing, and Bard artificial intelligence programs, which were released free of charge by three different manufacturers, in correctly answering questions about lenses, cataract, and refractive surgery, and to investigate whether they are superior to each other.

Methods: Seventy questions related to lens, cataract, and refractive surgery were obtained from the study questions section of the American Academy of Ophthalmology 2022 to 2023 Basic and Clinical Science Course Lens and Cataract and Refractive Surgery Books. The questions were asked separately for the ChatGPT, Bing, and Bard artificial intelligence programs. The answers were compared with answer keys and grouped as correct or incorrect. The accuracy rates of artificial intelligence programs were compared statistically.

Results: ChatGPT, Bing, and Bard chatbots gave correct answers to 35 (50%), 43 (61.4%), and 50 (71.4%) questions asked, respectively. The rate of correct answers to the questions of the Bard artificial intelligence program was significantly higher than that of ChatGPT (P = 0.009, Pearson's Chi-square test).

Conclusion: Although the currently released artificial intelligence chatbots can be used to access accurate information about lenses, cataracts, and refractive surgery, one should always be careful about the accuracy of the answers given.

目的:我们旨在评估 Chat Generative Pre-trained Transformer(ChatGPT)、Bing 和 Bard 人工智能程序(由三家不同制造商免费发布)在正确回答有关晶状体、白内障和屈光手术的问题方面的成功率,并研究它们之间是否存在优劣之分:从美国眼科学会 2022 至 2023 年基础与临床科学课程《透镜》和《白内障与屈光手术》书籍的学习问题部分获得了 70 个与透镜、白内障和屈光手术有关的问题。这些问题分别针对 ChatGPT、Bing 和 Bard 人工智能程序提出。将答案与答题卡进行比较,并按正确与否进行分组。统计比较了人工智能程序的准确率:ChatGPT、Bing 和 Bard 聊天机器人分别对 35 个(50%)、43 个(61.4%)和 50 个(71.4%)问题给出了正确答案。Bard 人工智能程序的问题正确回答率明显高于 ChatGPT(P = 0.009,皮尔逊卡方检验):尽管目前发布的人工智能聊天机器人可用于获取有关镜片、白内障和屈光手术的准确信息,但人们应始终注意所给出答案的准确性。
{"title":"Exploring Artificial Intelligence Programs' Understanding of Lens, Cataract, and Refractive Surgery Information.","authors":"Eyupcan Sensoy, Mehmet Citirik","doi":"10.4103/meajo.meajo_199_23","DOIUrl":"https://doi.org/10.4103/meajo.meajo_199_23","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to evaluate the success of Chat Generative Pre-trained Transformer (ChatGPT), Bing, and Bard artificial intelligence programs, which were released free of charge by three different manufacturers, in correctly answering questions about lenses, cataract, and refractive surgery, and to investigate whether they are superior to each other.</p><p><strong>Methods: </strong>Seventy questions related to lens, cataract, and refractive surgery were obtained from the study questions section of the American Academy of Ophthalmology 2022 to 2023 Basic and Clinical Science Course Lens and Cataract and Refractive Surgery Books. The questions were asked separately for the ChatGPT, Bing, and Bard artificial intelligence programs. The answers were compared with answer keys and grouped as correct or incorrect. The accuracy rates of artificial intelligence programs were compared statistically.</p><p><strong>Results: </strong>ChatGPT, Bing, and Bard chatbots gave correct answers to 35 (50%), 43 (61.4%), and 50 (71.4%) questions asked, respectively. The rate of correct answers to the questions of the Bard artificial intelligence program was significantly higher than that of ChatGPT (<i>P</i> = 0.009, Pearson's Chi-square test).</p><p><strong>Conclusion: </strong>Although the currently released artificial intelligence chatbots can be used to access accurate information about lenses, cataracts, and refractive surgery, one should always be careful about the accuracy of the answers given.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"173-176"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495292/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pro re nata Treatment of Diabetic Macular Edema with Cycles of Three Injections of Anti-vascular Endothelial Growth Factor Injections. 用三次抗血管内皮生长因子注射液循环治疗糖尿病性黄斑水肿。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_17_22
Ahmad Rehmani, Touka Banaee, Shadan Alwan, Elizabeth Urias, Lance Lyons, Jaafar El-Annan

Purpose: The purpose of this study was to report the visual and anatomic results at 12 and 24 months using the protocol of 3 monthly pro re nata (PRN) injections for diabetic macular edema (DME).

Methods: This was a retrospective chart review of 97 eyes with DME treated with a protocol of cycles consisting of 3 monthly injections of anti-vascular endothelial growth factor drugs on a PRN basis. Change in visual acuity was the main outcome measure. Macular thickness, number of injections, cycles, and visits in years 1 and 2 of follow-up were secondary outcomes.

Results: Ninety-six patients with a mean age of 60.9 ± 9.96 years were followed for a mean of 22.17 ± 12.30 months. Ninety-two (95.9%), 3 (3%), and 1 (1%) patients were started on bevacizumab, ranibizumab, and aflibercept, respectively. Of bevacizumab patients, 17 (18.2%) were eventually switched to aflibercept. The mean 12-month improvement (standard deviation [SD]) was + 3.3 (17.4) letters (95% confidence interval [CI] = +0.36-+7.05, P < 0.001) after an average (SD) of 5.97 (2.98) injections over a mean (SD) of 1.7 (1.0) three-injection cycles. The mean 24-month improvement (SD) was + 5.6 (13.0) letters (95% CI: -0.28-11.05, P = 0.0186) after an average (SD) of 8.72 (6.31) injections over a mean (SD) of 2.9 (2.1) three-injection cycles. The mean central macular thickness (SD) at baseline, 12 months, and 24 months was 374 ± 120, 322 ± 88, and 305 ± 70 µm. Optical coherence tomography was fluid free at 12 and 24 months in 27.6% and 46% of eyes, respectively.

Conclusion: Comparable to real-world studies, this protocol can stabilize or improve vision in more than 85% of DME patients over 24 months. The most important factor in improvement of vision is increasing number of injections and visits.

目的:本研究的目的是报告糖尿病性黄斑水肿(DME)患者采用每月3次按需注射(PRN)方案治疗12个月和24个月后的视觉和解剖效果:这是一项回顾性病历审查,对97只患有糖尿病性黄斑水肿的眼睛进行了治疗,治疗方案包括每月3次按时注射抗血管内皮生长因子药物。视力变化是衡量疗效的主要指标。黄斑厚度、注射次数、周期以及随访第1年和第2年的就诊次数是次要结果:96名患者的平均年龄为(60.9±9.96)岁,平均随访时间为(22.17±12.30)个月。92名(95.9%)、3名(3%)和1名(1%)患者分别开始使用贝伐珠单抗、雷尼单抗和阿夫利拜因。在贝伐珠单抗患者中,有17人(18.2%)最终改用了阿弗利贝赛普。在平均(标清)5.97(2.98)次注射、平均(标清)1.7(1.0)个注射周期后,12个月的平均改善(标准差[SD])为+3.3(17.4)个字母(95% 置信区间[CI] = +0.36-+7.05,P < 0.001)。平均(SD)注射 8.72 (6.31) 次,平均(SD)注射 3 次,平均(SD)注射 2.9 (2.1) 次,24 个月的平均改善(SD)为 + 5.6 (13.0) 个字母(95% CI:-0.28-11.05,P = 0.0186)。基线、12 个月和 24 个月时黄斑中心厚度的平均值(SD)分别为 374 ± 120、322 ± 88 和 305 ± 70 µm。12个月和24个月时,分别有27.6%和46%的眼睛光学相干断层扫描显示无积液:结论:与真实世界的研究结果相比,该方案可在 24 个月内稳定或改善 85% 以上 DME 患者的视力。视力改善的最重要因素是注射和就诊次数的增加。
{"title":"<i>Pro re nata</i> Treatment of Diabetic Macular Edema with Cycles of Three Injections of Anti-vascular Endothelial Growth Factor Injections.","authors":"Ahmad Rehmani, Touka Banaee, Shadan Alwan, Elizabeth Urias, Lance Lyons, Jaafar El-Annan","doi":"10.4103/meajo.meajo_17_22","DOIUrl":"10.4103/meajo.meajo_17_22","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to report the visual and anatomic results at 12 and 24 months using the protocol of 3 monthly <i>pro re nata</i> (PRN) injections for diabetic macular edema (DME).</p><p><strong>Methods: </strong>This was a retrospective chart review of 97 eyes with DME treated with a protocol of cycles consisting of 3 monthly injections of anti-vascular endothelial growth factor drugs on a PRN basis. Change in visual acuity was the main outcome measure. Macular thickness, number of injections, cycles, and visits in years 1 and 2 of follow-up were secondary outcomes.</p><p><strong>Results: </strong>Ninety-six patients with a mean age of 60.9 ± 9.96 years were followed for a mean of 22.17 ± 12.30 months. Ninety-two (95.9%), 3 (3%), and 1 (1%) patients were started on bevacizumab, ranibizumab, and aflibercept, respectively. Of bevacizumab patients, 17 (18.2%) were eventually switched to aflibercept. The mean 12-month improvement (standard deviation [SD]) was + 3.3 (17.4) letters (95% confidence interval [CI] = +0.36-+7.05, <i>P</i> < 0.001) after an average (SD) of 5.97 (2.98) injections over a mean (SD) of 1.7 (1.0) three-injection cycles. The mean 24-month improvement (SD) was + 5.6 (13.0) letters (95% CI: -0.28-11.05, <i>P</i> = 0.0186) after an average (SD) of 8.72 (6.31) injections over a mean (SD) of 2.9 (2.1) three-injection cycles. The mean central macular thickness (SD) at baseline, 12 months, and 24 months was 374 ± 120, 322 ± 88, and 305 ± 70 µm. Optical coherence tomography was fluid free at 12 and 24 months in 27.6% and 46% of eyes, respectively.</p><p><strong>Conclusion: </strong>Comparable to real-world studies, this protocol can stabilize or improve vision in more than 85% of DME patients over 24 months. The most important factor in improvement of vision is increasing number of injections and visits.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"141-148"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Population-based Study of the Prevalence of Cataract and Its Relationship with Smoking in the Northwest of Iran: The Azar Cohort Eye Study. 伊朗西北部白内障患病率及其与吸烟关系的人群研究:阿扎尔队列眼科研究
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_79_23
Shahryar Razzaghi, Ali F Khalili, Elnaz Faramarzi, Behzad F Motlagh, Ali H Zeinalzadeh

Purpose: The purpose of the to determine the prevalence of cataract and study the relationship of smoking and other potential risk factors with visually significant cataract.

Methods: This is a cross-sectional study based on the Azar cohort databases including 11,208 participants aged 35-70 years of the general population. According to the questionnaire, participants were divided into five groups in terms of smoking. Eye examinations were performed in two steps. The first step was performed by an optometrist, and in the second step, participants with poor red reflex or visual acuity of <8/10 were examined by an ophthalmologist for diagnosing cataract.

Results: Of the participants, 4992 (44.5%) were male and 6216 (55.5%) were female, with a mean age of 50.1 ± 9.27 years. The prevalence of visually significant cataract was 7.2%. The frequency of ex-smoking in the male and female population in the cataract group was significantly higher than that in the noncataract group (male: P = 0.008, female: P = 0.01), but after adjustment for age and education level, lost its significance (male odds ratio [OR] = 1.1 [0.8-1.5], P = 0.4; female OR = 1.5 [0.5-4], P = 0.3).

Conclusion: There is no association between cigarette smoking in different doses and the history of smoking with cataracts but other factors such as aging, education level, and underlying diseases including diabetes mellitus, hypertension, and myopia have statistically significant association with visually significant cataract.

目的:本研究旨在确定白内障的患病率,并研究吸烟和其他潜在风险因素与视觉上明显的白内障之间的关系:这是一项基于 Azar 队列数据库的横断面研究,包括 11 208 名年龄在 35-70 岁之间的普通人群。根据调查问卷,参与者按吸烟情况被分为五组。眼科检查分两步进行。第一步由验光师进行,第二步是对红色反射差或视力结果不佳的参与者进行检查:参与者中,男性 4992 人(44.5%),女性 6216 人(55.5%),平均年龄(50.1±9.27)岁。患有明显白内障的比例为 7.2%。白内障组男性和女性人群中曾吸烟的频率明显高于非白内障组(男性:P = 0.008,女性:P = 0.01),但在调整年龄和教育水平后,其显著性降低(男性比值比 [OR] = 1.1 [0.8-1.5],P = 0.4;女性比值比 [OR] = 1.5 [0.5-4],P = 0.3):结论:不同剂量的吸烟和吸烟史与白内障之间没有关联,但其他因素,如年龄、受教育程度和基础疾病(包括糖尿病、高血压和近视)与视觉上明显的白内障有显著的统计学关联。
{"title":"A Population-based Study of the Prevalence of Cataract and Its Relationship with Smoking in the Northwest of Iran: The Azar Cohort Eye Study.","authors":"Shahryar Razzaghi, Ali F Khalili, Elnaz Faramarzi, Behzad F Motlagh, Ali H Zeinalzadeh","doi":"10.4103/meajo.meajo_79_23","DOIUrl":"10.4103/meajo.meajo_79_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the to determine the prevalence of cataract and study the relationship of smoking and other potential risk factors with visually significant cataract.</p><p><strong>Methods: </strong>This is a cross-sectional study based on the Azar cohort databases including 11,208 participants aged 35-70 years of the general population. According to the questionnaire, participants were divided into five groups in terms of smoking. Eye examinations were performed in two steps. The first step was performed by an optometrist, and in the second step, participants with poor red reflex or visual acuity of <8/10 were examined by an ophthalmologist for diagnosing cataract.</p><p><strong>Results: </strong>Of the participants, 4992 (44.5%) were male and 6216 (55.5%) were female, with a mean age of 50.1 ± 9.27 years. The prevalence of visually significant cataract was 7.2%. The frequency of ex-smoking in the male and female population in the cataract group was significantly higher than that in the noncataract group (male: <i>P</i> = 0.008, female: <i>P</i> = 0.01), but after adjustment for age and education level, lost its significance (male odds ratio [OR] = 1.1 [0.8-1.5], <i>P</i> = 0.4; female OR = 1.5 [0.5-4], <i>P</i> = 0.3).</p><p><strong>Conclusion: </strong>There is no association between cigarette smoking in different doses and the history of smoking with cataracts but other factors such as aging, education level, and underlying diseases including diabetes mellitus, hypertension, and myopia have statistically significant association with visually significant cataract.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"156-163"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Acute Iris Transillumination Following Coronavirus Disease 2019 Infection. 2019年冠状病毒病感染后的双侧急性虹膜透亮。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_69_24
Abdulrahman F Albloushi, Ghada Alabdi, Hend Elmutawi

Bilateral acute iris transillumination (BAIT) syndrome is an uncommon disorder marked by sudden dispersion of pigment in the anterior chamber, iris sphincter muscle paralysis, and elevated intraocular pressure. This syndrome has been linked to viral infections and the administration of fluoroquinolones such as moxifloxacin. This study presents a case of a 54-year-old male, otherwise in good health, who developed BAIT syndrome 1 week after experiencing an upper respiratory tract infection that followed a coronavirus disease 2019 (COVID-19) diagnosis. The patient was effectively treated with topical prednisolone acetate and antiglaucoma medications. Further studies are required to investigate the relationship between COVID-19 and BAIT to enhance understanding of its pathophysiology.

双侧急性虹膜透光综合征(BAIT)是一种不常见的疾病,其特征是前房色素突然消散、虹膜括约肌麻痹和眼压升高。这种综合征与病毒感染和服用氟喹诺酮类药物(如莫西沙星)有关。本研究介绍了一例 54 岁男性患者的病例,该患者健康状况良好,在被诊断为冠状病毒病 2019(COVID-19)后出现上呼吸道感染,1 周后出现 BAIT 综合征。患者接受了醋酸泼尼松龙外用药和抗青光眼药物的有效治疗。需要进一步研究 COVID-19 与 BAIT 之间的关系,以加深对其病理生理学的了解。
{"title":"Bilateral Acute Iris Transillumination Following Coronavirus Disease 2019 Infection.","authors":"Abdulrahman F Albloushi, Ghada Alabdi, Hend Elmutawi","doi":"10.4103/meajo.meajo_69_24","DOIUrl":"https://doi.org/10.4103/meajo.meajo_69_24","url":null,"abstract":"<p><p>Bilateral acute iris transillumination (BAIT) syndrome is an uncommon disorder marked by sudden dispersion of pigment in the anterior chamber, iris sphincter muscle paralysis, and elevated intraocular pressure. This syndrome has been linked to viral infections and the administration of fluoroquinolones such as moxifloxacin. This study presents a case of a 54-year-old male, otherwise in good health, who developed BAIT syndrome 1 week after experiencing an upper respiratory tract infection that followed a coronavirus disease 2019 (COVID-19) diagnosis. The patient was effectively treated with topical prednisolone acetate and antiglaucoma medications. Further studies are required to investigate the relationship between COVID-19 and BAIT to enhance understanding of its pathophysiology.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"185-187"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual Outcome and Complications in White Mature Cataracts after Phacoemulsification. 白内障超声乳化术后的视觉效果和并发症
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_100_23
Komal Jaiswal, Rishabh Rathi, Amisha Jain, Ashish Gaur, Nitin Nema

Purpose: To identify risk factors and perioperative complications and assess postoperative visual outcome in patients of white mature cataracts undergoing phacoemulsification surgery.

Methods: This cross-sectional study was conducted on 46 patients of white mature cataract undergoing phacoemulsification. Preoperatively, a detailed ocular examination was done, and anterior chamber depth (ACD) and lens thickness (LT) were measured on ultrasound biomicroscopy. Intraoperative and postoperative complications (on days 1, 7, and 30) and best-corrected visual acuity on postoperative day 30 were noted.

Results: The mean age of patients was 60.78 ± 9.001 years. The study group consisted of 41.3% of males and 58.7% of females. 8 (19.56%) cases encountered complications during phacoemulsification surgery. The intraoperative complications were capsulorhexis-related in 5 (10.86%) patients, posterior capsular rent in 2 (4.3%) patients, and 1 (2.17%) case had zonular dialysis. There was no difference in mean ACD and LT in cases who developed complications and those who underwent uneventful surgery (P > 0.05). The commonly observed postoperative complications on day 1 were corneal edema (41.3%), anterior chamber flare (45.65%), and cells (39.13%) which resolved with routine topical medications. All patients showed a significant reduction in postoperative intraocular pressure (P < 0.001). A total of 37 (80.43%) eyes regained vision between 6/6 and 6/9 postoperatively (P < 0.001).

Conclusion: Phacoemulsification surgery is safe in white mature cataract that results in significant visual improvement. Common intraoperative complications are capsule related, while frequently encountered postoperative complications are corneal edema and anterior chamber reaction. Preoperative ACD and LT have no role in predicting intraoperative complications.

目的:确定接受超声乳化手术的白色成熟白内障患者的风险因素和围手术期并发症,并评估术后视觉效果:这项横断面研究针对 46 名接受超声乳化手术的白色成熟白内障患者。术前进行了详细的眼部检查,并通过超声生物显微镜测量了前房深度(ACD)和晶状体厚度(LT)。记录了术中和术后并发症(第 1、7 和 30 天)以及术后第 30 天的最佳矫正视力:患者平均年龄(60.78±9.001)岁。研究组中男性占 41.3%,女性占 58.7%。8例(19.56%)患者在乳化手术中出现并发症。5例(10.86%)患者的术中并发症与囊膜脱落有关,2例(4.3%)患者出现后囊膜脱落,1例(2.17%)患者出现虹膜透析。出现并发症的病例与手术顺利的病例在平均 ACD 和 LT 方面没有差异(P > 0.05)。术后第 1 天常见的并发症是角膜水肿(41.3%)、前房外翻(45.65%)和细胞(39.13%),这些并发症在常规局部用药后即可缓解。所有患者的术后眼压都有明显下降(P < 0.001)。共有 37 只眼睛(80.43%)在术后视力恢复到 6/6 到 6/9 之间(P < 0.001):结论:对于白内障患者来说,超声乳化手术是安全的,能显著改善视力。术中常见的并发症与囊袋有关,而术后常见的并发症是角膜水肿和前房反应。术前ACD和LT在预测术中并发症方面没有作用。
{"title":"Visual Outcome and Complications in White Mature Cataracts after Phacoemulsification.","authors":"Komal Jaiswal, Rishabh Rathi, Amisha Jain, Ashish Gaur, Nitin Nema","doi":"10.4103/meajo.meajo_100_23","DOIUrl":"https://doi.org/10.4103/meajo.meajo_100_23","url":null,"abstract":"<p><strong>Purpose: </strong>To identify risk factors and perioperative complications and assess postoperative visual outcome in patients of white mature cataracts undergoing phacoemulsification surgery.</p><p><strong>Methods: </strong>This cross-sectional study was conducted on 46 patients of white mature cataract undergoing phacoemulsification. Preoperatively, a detailed ocular examination was done, and anterior chamber depth (ACD) and lens thickness (LT) were measured on ultrasound biomicroscopy. Intraoperative and postoperative complications (on days 1, 7, and 30) and best-corrected visual acuity on postoperative day 30 were noted.</p><p><strong>Results: </strong>The mean age of patients was 60.78 ± 9.001 years. The study group consisted of 41.3% of males and 58.7% of females. 8 (19.56%) cases encountered complications during phacoemulsification surgery. The intraoperative complications were capsulorhexis-related in 5 (10.86%) patients, posterior capsular rent in 2 (4.3%) patients, and 1 (2.17%) case had zonular dialysis. There was no difference in mean ACD and LT in cases who developed complications and those who underwent uneventful surgery (<i>P</i> > 0.05). The commonly observed postoperative complications on day 1 were corneal edema (41.3%), anterior chamber flare (45.65%), and cells (39.13%) which resolved with routine topical medications. All patients showed a significant reduction in postoperative intraocular pressure (<i>P</i> < 0.001). A total of 37 (80.43%) eyes regained vision between 6/6 and 6/9 postoperatively (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Phacoemulsification surgery is safe in white mature cataract that results in significant visual improvement. Common intraoperative complications are capsule related, while frequently encountered postoperative complications are corneal edema and anterior chamber reaction. Preoperative ACD and LT have no role in predicting intraoperative complications.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"129-135"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinopathy of Prematurity in Extreme Preterm and Extreme Low-birth-weight Infants: Incidence, Course, and Risk Factors. 极早产儿和极低出生体重儿的早产儿视网膜病变:发病率、病程和风险因素。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_15_24
T Lekha, Divya Balakrishnan, A Giridhar, Divya Alex, Anubhav Goyal

Purpose: The purpose of this study was to analyze the incidence of retinopathy of prematurity (ROP), treatment requiring ROP (TROP), course, and systemic risk factors in extreme preterm or extreme low-birth-weight babies.

Methods: A retrospective analysis of neonatal intensive care unit-based ROP screening from January to December 2021 in a tier-2 city in Kerala, India, was done. Inclusion criteria were gestational age (GA) ≤28 weeks or birth weight ≤1000 g. ROP screening and treatment were done according to the International Classification of ROP guidelines. Treatment was indicated in babies with type 1 ROP or aggressive ROP. Details of ROP screening, treatment, and neonatal risk factors were collected from the records. The results were statistically analyzed, and P < 0.05 was considered statistically significant.

Results: The study included 54 babies with a mean GA of 27.47 ± 1.76 weeks and a mean BW of 847.43 ± 189.22 g. ROP was detected at an average postmenstrual age of 33.8 ± 1.7 weeks. The incidence of any ROP and TROP was 87% and 19.14%, respectively. All babies with TROP were managed with laser or intravitreal antivascular endothelial growth factor injection or both. ROP resolved spontaneously in 60%, but those with Zone 2 disease had delayed regression. Inotropic support and anemia were found to increase the risk for ROP.

Conclusion: The incidence and outcome of any ROP and TROP in this study are comparable to the rates reported globally, and this reflects the improvement in neonatal care. The use of inotropes and anemia may increase the risk for ROP and needs to be managed judiciously.

目的:本研究旨在分析极早产儿或极低出生体重儿的早产儿视网膜病变(ROP)发病率、需要ROP治疗(TROP)、病程和系统性风险因素:方法:对印度喀拉拉邦一个二线城市 2021 年 1 月至 12 月期间新生儿重症监护室的早产儿视网膜病变筛查进行了回顾性分析。纳入标准为胎龄(GA)≤28 周或出生体重≤1000 克。根据国际视网膜病变分类指南进行视网膜病变筛查和治疗。治疗适用于 1 型早产儿视网膜病变或侵袭性早产儿视网膜病变的婴儿。从记录中收集了有关视网膜病变筛查、治疗和新生儿风险因素的详细信息。研究结果经统计学分析,P < 0.05 为差异有统计学意义:研究共纳入 54 名婴儿,平均月龄(27.47±1.76)周,平均体重(847.43±189.22)克。任何 ROP 和 TROP 的发生率分别为 87% 和 19.14%。所有患有 TROP 的婴儿都接受了激光或玻璃体内抗血管内皮生长因子注射治疗,或两者兼用。60%的早产儿可自然消退,但患有2区疾病的早产儿消退延迟。研究发现,肌力支持和贫血会增加发生 ROP 的风险:结论:本研究中任何 ROP 和 TROP 的发生率和结果与全球报告的发生率相当,这反映了新生儿护理的改善。使用肌注药物和贫血可能会增加发生 ROP 的风险,因此需要谨慎处理。
{"title":"Retinopathy of Prematurity in Extreme Preterm and Extreme Low-birth-weight Infants: Incidence, Course, and Risk Factors.","authors":"T Lekha, Divya Balakrishnan, A Giridhar, Divya Alex, Anubhav Goyal","doi":"10.4103/meajo.meajo_15_24","DOIUrl":"https://doi.org/10.4103/meajo.meajo_15_24","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to analyze the incidence of retinopathy of prematurity (ROP), treatment requiring ROP (TROP), course, and systemic risk factors in extreme preterm or extreme low-birth-weight babies.</p><p><strong>Methods: </strong>A retrospective analysis of neonatal intensive care unit-based ROP screening from January to December 2021 in a tier-2 city in Kerala, India, was done. Inclusion criteria were gestational age (GA) ≤28 weeks or birth weight ≤1000 g. ROP screening and treatment were done according to the International Classification of ROP guidelines. Treatment was indicated in babies with type 1 ROP or aggressive ROP. Details of ROP screening, treatment, and neonatal risk factors were collected from the records. The results were statistically analyzed, and <i>P</i> < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The study included 54 babies with a mean GA of 27.47 ± 1.76 weeks and a mean BW of 847.43 ± 189.22 g. ROP was detected at an average postmenstrual age of 33.8 ± 1.7 weeks. The incidence of any ROP and TROP was 87% and 19.14%, respectively. All babies with TROP were managed with laser or intravitreal antivascular endothelial growth factor injection or both. ROP resolved spontaneously in 60%, but those with Zone 2 disease had delayed regression. Inotropic support and anemia were found to increase the risk for ROP.</p><p><strong>Conclusion: </strong>The incidence and outcome of any ROP and TROP in this study are comparable to the rates reported globally, and this reflects the improvement in neonatal care. The use of inotropes and anemia may increase the risk for ROP and needs to be managed judiciously.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"136-140"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Childhood Myopic Foveoschisis in LRPAP1-associated Myopia. LRPAP1相关性近视中的儿童近视眼窝畸形。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_151_23
Mohammad Almazyead, Abdullmajeed S Alfakhri, Sulaiman M Alsulaiman

This case reports the development of foveoschisis in a child with high myopia due to a homozygous LRPAP1 pathogenic variant. A 9-year-old girl with high myopia due to a homozygous mutation in the LRPAP1 gene and a history of retinal detachment repair in her right eye, presented on follow-up with progressive myopic foveoschisis in the left eye noted on optical coherence tomography. The schitic changes evolved into a lamellar macular hole and required vitrectomy. Postoperatively, stabilization of the condition was achieved. Myopic foveoschisis could develop in childhood in the setting of recessive LRPAP1 pathogenic variants. Long_term follow-up is needed to determine the natural history of early-onset myopic foveoschisis.

本病例报告了一名因 LRPAP1 基因同源变异而患有高度近视的儿童出现的眼窝裂伤。一名 9 岁女孩因 LRPAP1 基因同源突变而患有高度近视,右眼曾进行过视网膜脱离修复手术。裂孔病变演变为片状黄斑孔,需要进行玻璃体切除术。术后病情稳定。隐性 LRPAP1 致病变体可能会在儿童期出现近视性黄斑裂孔。需要进行长期随访,以确定早发近视眼窝沟封闭的自然史。
{"title":"Childhood Myopic Foveoschisis in LRPAP1-associated Myopia.","authors":"Mohammad Almazyead, Abdullmajeed S Alfakhri, Sulaiman M Alsulaiman","doi":"10.4103/meajo.meajo_151_23","DOIUrl":"10.4103/meajo.meajo_151_23","url":null,"abstract":"<p><p>This case reports the development of foveoschisis in a child with high myopia due to a homozygous LRPAP1 pathogenic variant. A 9-year-old girl with high myopia due to a homozygous mutation in the LRPAP1 gene and a history of retinal detachment repair in her right eye, presented on follow-up with progressive myopic foveoschisis in the left eye noted on optical coherence tomography. The schitic changes evolved into a lamellar macular hole and required vitrectomy. Postoperatively, stabilization of the condition was achieved. Myopic foveoschisis could develop in childhood in the setting of recessive LRPAP1 pathogenic variants. Long_term follow-up is needed to determine the natural history of early-onset myopic foveoschisis.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"182-184"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Middle East African Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1